Literature DB >> 4759937

Immunotherapy of the Dunning leukaemia with thymic extracts.

B A Khaw, A H Rule.   

Abstract

Injections of thymic extract (TE), TE primed lymphocytes or normal lymph node cells were effective in bringing about total remission of the Dunning leukaemia in inbred Fisher CD rats. Survival greater than 365 days occurred in 10-80% of the various treated groups whereas untreated leukaemic rats, or leukaemic rats treated with spleen "mock thymus extract" or bovine serum albumin, died within an average of 10-17 days. Administration of antilymphocyte serum into leukaemic rats enhanced their death rate. Stimulation of cell mediated immunity via the production of functional thymus stimulated lymphocytes is postulated as the mechanism by which tumour rejection occurred.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4759937      PMCID: PMC2008900          DOI: 10.1038/bjc.1973.150

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  Perspectives on oncogenesis: does immunity stimulate or inhibit neoplasia?

Authors:  R T Prehn
Journal:  J Reticuloendothel Soc       Date:  1971-07

2.  Reduction in the incidence of wasting disease in neonatally thymectomized CBA-W mice by the injection of thymosin.

Authors:  Y Asanuma; A L Goldstein; A White
Journal:  Endocrinology       Date:  1970-03       Impact factor: 4.736

3.  Skin-reactive soluble antigen from intestinal cancer-cell-membranes and relationship to carcinoembryonic antigens.

Authors:  A Hollinshead; D Glew; B Bunnag; P Gold; R Herberman
Journal:  Lancet       Date:  1970-06-06       Impact factor: 79.321

4.  Active immunotherapy for acute lymphoblastic leukaemia.

Authors:  G Mathé; J L Amiel; L Schwarzenberg; M Schneider; A Cattan; J R Schlumberger; M Hayat; F De Vassal
Journal:  Lancet       Date:  1969-04-05       Impact factor: 79.321

Review 5.  Essential relationship between the lymphoid system, immunity, and malignancy.

Authors:  R A Good; J Finstad
Journal:  Natl Cancer Inst Monogr       Date:  1969-07

6.  Effect of thymosin and an antithymosin serum on allograft survival in mice.

Authors:  M A Hardy; J Quint; A L Goldstein; D State; A White
Journal:  Proc Natl Acad Sci U S A       Date:  1968-11       Impact factor: 11.205

7.  Influence of thymosin on immunological competence of lymphoid cells from thymectomized mice.

Authors:  L W Law; A L Goldstein; A White
Journal:  Nature       Date:  1968-09-28       Impact factor: 49.962

8.  Impaired immunologic reactivity and recurrence following cancer surgery.

Authors:  F R Eilber; D L Morton
Journal:  Cancer       Date:  1970-02       Impact factor: 6.860

9.  Acceleration by thymosin of the development of resistance to murine sarcoma virus-induced tumor in mice.

Authors:  M Zisblatt; A L Goldstein; F Lilly; A White
Journal:  Proc Natl Acad Sci U S A       Date:  1970-08       Impact factor: 11.205

10.  Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin).

Authors:  A L Goldstein; F D Slater; A White
Journal:  Proc Natl Acad Sci U S A       Date:  1966-09       Impact factor: 11.205

View more
  7 in total

1.  Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide.

Authors:  A L Goldstein; T L Low; M McAdoo; J McClure; G B Thurman; J Rossio; C Y Lai; D Chang; S S Wang; C Harvey; A H Ramel; J Meienhofer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

2.  Immunotherapy of cancer with thymosin.

Authors:  J L Rossio; A L Goldstein
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

3.  Modulation of terminal deoxynucleotidyl transferase activity by thymosin.

Authors:  S K Hu; T L Low; A L Goldstein
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

4.  Complete amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations.

Authors:  T L Low; S K Hu; A L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

5.  Effect of different components of the thymic stroma on the onset of AKR leukaemia.

Authors:  M Fournier; E F Potworowski
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

6.  Thymax, a gross thymic extract, exerts cell cycle arrest and apoptosis in Ehrlich ascites carcinoma in vivo.

Authors:  Nariman K Badr El-Din; Azza I Othman; Maggie E Amer; Mamdooh Ghoneum
Journal:  Heliyon       Date:  2022-03-05

Review 7.  Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications?

Authors:  P Samara; K Ioannou; O E Tsitsilonis
Journal:  Vitam Horm       Date:  2016-05-27       Impact factor: 3.421

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.